Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Gallagher

Showing results (281-290 of 300) with videos related to

Pageof 30
Sort By:
The Nebraska Medical Journal|December 1, 1991
Combined pancreas--kidney transplantation in NebraskaR J Stratta, R J Taylor, B H Zorn, et al.
Plos One|December 28, 2020
The role of the MAD2-TLR4-MyD88 axis in paclitaxel resistance in ovarian cancerMark Bates, Cathy D Spillane, Michael F Gallagher, et al.
Dalton Transactions (Cambridge, England : 2003)|June 16, 2026
Development and comparative study of a hydrophilic bis-triazolyl-phenanthroline ligand and two bis-triazolyl-pyridine ligandsYong Qiang Wan, Yang-Yang Zhang, Shi Lin Zhang, et al.
Journal of Ovarian Research|January 21, 2012
Suppression of cancer stemness p21-regulating mRNA and microRNA signatures in recurrent ovarian cancer patient samplesMichael F Gallagher, Cynthia Cbb Heffron, Alexandros Laios, et al.
Translational Lung Cancer Research|May 20, 2021
MicroRNA expression profiling and biomarker validation in treatment-naïve and drug resistant non-small cell lung cancerLauren MacDonagh, Michael F Gallagher, Brendan Ffrench, et al.
Oncotarget|October 27, 2017
Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLCLauren MacDonagh, Michael F Gallagher, Brendan Ffrench, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2012
Acylprolinamides: a new class of peptide deformylase inhibitors with in vivo antibacterial activityJeffrey M Axten, Jesús R Medina, Charles W Blackledge, et al.
The Journal of Biological Chemistry|May 2, 1997
Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP siteP R Young, M M McLaughlin, S Kumar, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Real-world radiology data for artificial intelligence-driven cancer support systems and biomarker developmentD Navarro-Garcia, A Marcos, R Beets-Tan, et al.
Journal of Medicinal Chemistry|September 27, 1996
1-substituted 4-aryl-5-pyridinylimidazoles: a new class of cytokine suppressive drugs with low 5-lipoxygenase and cyclooxygenase inhibitory potencyJ C Boehm, J M Smietana, M E Sorenson, et al.
Pageof 30

Showing results (281-290 of 300) with videos related to

Sort By:
Pageof 30
The Nebraska Medical Journal|December 1, 1991
Combined pancreas--kidney transplantation in NebraskaR J Stratta, R J Taylor, B H Zorn, et al.
Plos One|December 28, 2020
The role of the MAD2-TLR4-MyD88 axis in paclitaxel resistance in ovarian cancerMark Bates, Cathy D Spillane, Michael F Gallagher, et al.
Dalton Transactions (Cambridge, England : 2003)|June 16, 2026
Development and comparative study of a hydrophilic bis-triazolyl-phenanthroline ligand and two bis-triazolyl-pyridine ligandsYong Qiang Wan, Yang-Yang Zhang, Shi Lin Zhang, et al.
Journal of Ovarian Research|January 21, 2012
Suppression of cancer stemness p21-regulating mRNA and microRNA signatures in recurrent ovarian cancer patient samplesMichael F Gallagher, Cynthia Cbb Heffron, Alexandros Laios, et al.
Translational Lung Cancer Research|May 20, 2021
MicroRNA expression profiling and biomarker validation in treatment-naïve and drug resistant non-small cell lung cancerLauren MacDonagh, Michael F Gallagher, Brendan Ffrench, et al.
Oncotarget|October 27, 2017
Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLCLauren MacDonagh, Michael F Gallagher, Brendan Ffrench, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2012
Acylprolinamides: a new class of peptide deformylase inhibitors with in vivo antibacterial activityJeffrey M Axten, Jesús R Medina, Charles W Blackledge, et al.
The Journal of Biological Chemistry|May 2, 1997
Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP siteP R Young, M M McLaughlin, S Kumar, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Real-world radiology data for artificial intelligence-driven cancer support systems and biomarker developmentD Navarro-Garcia, A Marcos, R Beets-Tan, et al.
Journal of Medicinal Chemistry|September 27, 1996
1-substituted 4-aryl-5-pyridinylimidazoles: a new class of cytokine suppressive drugs with low 5-lipoxygenase and cyclooxygenase inhibitory potencyJ C Boehm, J M Smietana, M E Sorenson, et al.
Pageof 30